Difference between revisions of "Stop-sertraline"
From Psychiatrienet
| (One intermediate revision by one other user not shown) | |||
| Line 2: | Line 2: | ||
| from = sertraline | | from = sertraline | ||
| stop = {{StopAlgemeen}}<ref>{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}</ref>: | | stop = {{StopAlgemeen}}<ref>{{Pubmed|9646889|Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87}}</ref>: | ||
| − | * | + | * 150 mg/day <ref>[Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.](dutch)</ref>{{refBazire}}<ref>{{Pubmed|11347722|Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97}}</ref>: |
:*'''Day 1:''' reduce dosage of sertraline to 100 mg/day. | :*'''Day 1:''' reduce dosage of sertraline to 100 mg/day. | ||
:* '''Day 15:''' reduce dosage of sertraline to 50 mg/day. | :* '''Day 15:''' reduce dosage of sertraline to 50 mg/day. | ||
:* '''Day 29:''' stop administration of sertraline. | :* '''Day 29:''' stop administration of sertraline. | ||
}} | }} | ||
Latest revision as of 08:44, 2 August 2011
| ||||||||||||||||||||||
Stop sertraline - In general after long-term maintenance treatment, the best is to reduce the dose by about 25% every 4-6 weeks. An apt pharmaceutical dose (tablet, capsule, mixture) is not always available. In these cases one should be creative with dosing.[1][2]
- Another, more risky, possibility is being at a certain dose to use the following scheme:[3]:
- 150 mg/day [4][5][6]:
- Day 1: reduce dosage of sertraline to 100 mg/day.
- Day 15: reduce dosage of sertraline to 50 mg/day.
- Day 29: stop administration of sertraline.
- ↑ The UK Drug and Therapeutics Bulletin; 1999;37:49-52
- ↑ Editor: please note that not all dosages are available in pharmacy. So now and then you should be creative.
- ↑ Rosenbaum JF et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998 Jul 15;44(2):77-87
- ↑ [Moleman P, Geneesmiddelen voor de geest: een praktische gids. Amsterdam: Nieuwezijds; 2007. p.55.](dutch)
- ↑ Bazire S, Psychotropic Drug Directory 2010. Aberdeen: HealthComm UK Ltd; 2010.
- ↑ Haddad PM. Antidepressant discontinuation syndromes. Drug Saf. 2001;24(3):183-97
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
